Failure of 5-day vinblastine infusion in the treatment of patients with advanced refractory breast cancer.
D001772:Blood Cell Count / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D009362:Neoplasm Metastasis; D014747:Vinblastine / Q000009:adverse effects / Q000627:therapeutic use*
D014747:Vinblastine